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In vitro FRAP reveals the ATP-dependent nuclear 
mobilization of the exon junction complex 
protein SRm160
 
Stefan Wagner, Simion Chiosea, Maria Ivshina, and Jeffrey A. Nickerson
 
Department of Cell Biology, University of Massachusetts Medical School, Worcester, MA 01655
 
e present a new in vitro system for characteriz-
ing the binding and mobility of enhanced
 
green fluorescent protein (EGFP)–labeled nuclear
proteins by fluorescence recovery after photobleaching in
digitonin-permeabilized cells. This assay reveals that SRm160,
a splicing coactivator and component of the exon junction
complex (EJC) involved in RNA export, has an adenosine
triphosphate (ATP)–dependent mobility. Endogenous SRm160,
lacking the EGFP moiety, could also be released from
sites at splicing speckled domains by an ATP-dependent
mechanism. A second EJC protein, RNPS1, also has an
W
 
ATP-dependent mobility, but SRm300, a protein that binds
to SRm160 and participates with it in RNA splicing, remains
immobile after ATP supplementation. This finding suggests
that SRm160-containing RNA export, but not splicing,
complexes have an ATP-dependent mobility. We propose
that RNA export complexes have an ATP-regulated mechan-
ism for release from binding sites at splicing speckled
domains. In vitro fluorescence recovery after photobleaching
is a powerful tool for identifying cofactors required for
nuclear binding and mobility.
 
Introduction
 
RNA splicing is coupled to RNA export from the nucleus;
the mRNAs produced from intron-containing precursors are
exported much more efficiently from the nucleus than are
identical mRNAs produced without splicing (Luo and Reed,
1999). SRm160 is a coactivator of splicing that remains per-
sistently bound to mRNAs after intron removal (Blencowe
et al., 1998) at sites 20–24 nucleotides upstream from exon–
exon junctions in a complex also containing DEK, RNPS1,
Y14, the mRNA export factor Aly/REF, and Magoh (Ka-
taoka et al., 2000, 2001; Le Hir et al., 2000a,b, 2001).
Formation of this exon junction complex (EJC) is splicing
dependent. In vitro, at least two proteins of the complex,
Y14 and Magoh, bind to the TAP/p15 heterodimer (Ka-
 
taoka et al., 2001) whose homologues are essential for
the nuclear export of most mRNA (Herold et al., 2001).
SRm160 stimulates 3
 

 
 end cleavage of transcripts, and its
overexpression causes the appearance of intron-containing
RNAs in the cytoplasm (McCracken et al., 2002). The teth-
ering of SRm160 to transcripts lacking an active intron
stimulates their 3
 

 
 end cleavage and enhances their expression
(McCracken et al., 2003; Wiegand et al., 2003).
The microscopic observation of fluorescent fusion proteins
in living cells is a powerful tool for measuring intracellular
dynamics. Time-lapse studies can track the movement of
larger cellular structures, whereas FRAP is ideal for measuring
the intracellular mobility or binding of fluorescently tagged
proteins (Lippincott-Schwartz et al., 2001). The apparent
mobility of several nuclear proteins has been reported, in-
cluding histone H1.1 (Lever et al., 2000; Misteli et al.,
2000), the glucocorticoid receptor (McNally et al., 2000),
the estrogen receptor (Stenoien et al., 2001), ataxin (Ste-
noien et al., 2002), the nucleolar protein fibrillarin
(Phair and Misteli, 2000), the nucleosomal binding protein
HMG-17 (Phair and Misteli, 2000), the transcription factor
Runx (Harrington et al., 2002), and the RNA splicing factor
ASF/SF2 (Kruhlak et al., 2000; Phair and Misteli, 2000). All
of these proteins recover from photobleaching at rates much
slower than would be predicted for diffusing proteins of
similar size. These decreased apparent mobilities may be
imposed either by equilibrium interactions with structures
such as chromatin and the nuclear matrix or by transient
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binding in large complexes (Nickerson, 2001). The regulation
of these interactions has been explored by measuring changes
in FRAP recovery rates after metabolic or drug manipulations;
e.g., in transcriptionally inhibited cells (Kruhlak et al., 2000;
Phair and Misteli, 2000), with steroid receptor agonists and
antagonists (Stenoien et al., 2001), in the presence of protea-
somal inhibitors (Stenoien et al., 2001, 2002), and in energy-
depleted cells (Phair and Misteli, 2000; Stenoien et al., 2001;
Calapez et al., 2002). It has recently been reported that the
FRAP recovery rates of poly(A) binding protein II and TAP
are significantly reduced after a treatment designed to reduce
cell ATP levels (Calapez et al., 2002).
Here, we present a system for performing FRAP in the nu-
clei of digitonin-permeabilized cells, allowing the easy identi-
fication of cofactors required for nuclear protein binding and
mobility. Visualized in this way, the mobilization of EGFP fu-
sion proteins with SRm160 and RNPS1, two constituents of
the EJC, required ATP. The spliceosomal SRm160 binding
protein SRm300 (Blencowe et al., 2000) was not present in
ATP-mobilized complexes, suggesting that ATP animates
RNA export rather than RNA splicing complexes.
 
Results
 
The apparent mobility of EGFP-SRm160 was measured by
FRAP in HeLa cells stably expressing the fusion protein.
EGFP-SRm160 was most concentrated in splicing speckled
domains, which is consistent with previous results (Wagner
et al., 2003). Additionally, EGFP-SRm160 was also visible
at a lower concentration within the surrounding nucleo-
plasm. Photobleaching experiments were exclusively per-
formed by bleaching splicing speckled domains because it
was difficult to obtain reliable recovery quantitation for the
nucleoplasmic pool without overexpression of the fluores-
cent protein. The half time of recovery for EGFP-SRm160
at 37
 

 
C was 20 s with a 90% recovery and an immobile frac-
tion of 
 

 
10% (Fig. 1). In comparison, the half time of re-
covery of the prototypic splicing factor SC35 was shorter, 10 s
with an immobile fraction of 
 

 
10% (unpublished data). It
has been reported that the EGFP fusion protein of ASF/SF2,
an SR protein and splicing factor, has a photobleaching re-
covery half time in the range of 3–25 s depending on the cell
line (Kruhlak et al., 2000; Phair and Misteli, 2001).
In these FRAP experiments, photobleached protein bound
to sites in speckled domains is exchanging with unbleached
protein from other sites. The binding of SRm160 to splicing
speckled domains has been reported previously (Blencowe et
al., 1994; Wan et al., 1994; Wagner et al., 2003) and is con-
firmed by experiments reported in Fig. 1 A. In all FRAP ex-
periments where fluorescence recovery was observed in the
photobleached speckled domain, a corresponding decrease
in fluorescence was measured in unbleached speckled
domains. Because diffusion is rapid relative to our measured
fluorescence recovery rates, we interpret these experiments as
measuring the tightness of binding of fluorescent fusion pro-
teins to sites at bleached and unbleached splicing speckled
domains (Phair and Misteli, 2001; Lele, T., P. Oh, and D.
Ingber, personal communication). The immobile fraction
represents protein bound irreversibly over the time course of
the experiment.
To assess the energy dependence of SRm160 mobiliza-
tion, we first performed FRAP at room temperature. Recov-
ery was slowed only slightly (unpublished data). Next, we re-
duced ATP levels by treating cells with 10 mM sodium azide
plus 6 mM 2-deoxyglucose in the absence of glucose for 15–
30 min. This reduction resulted in a small but significant
decrease in the FRAP-measured mobility of EGFP-SRm160
(unpublished data). However, measurement of ATP levels
by luciferase assay showed that after 30 and 45 min in azide/
2-deoxyglucose, ATP concentrations had declined only 71%
and 83%, respectively (Table I). Because ATP levels in cul-
tured cells and tissues are 2–5 mM, and because Kms for
ATP are typically on the order of 10–200 
 

 
M, there might
be more than sufficient ATP persisting to maintain an ATP-
dependent EGFP-SRm160 mobilization.
To resolve this point, we extended the FRAP technique
into a novel in vitro system for biochemically characteriz-
Figure 1. Recovery of EGFP-SRm160 fluorescence after photobleaching in live cells. (A) Images of this HeLa cell stably expressing EGFP-SRm160 
were taken before (Pre-Bleach), immediately after (Bleach), and at intervals after bleaching (16 and 32 s). The bleached area is outlined by a 
white square. Bar, 10 m. (B) The recovery curve for EGFP-SRm160 in stably expressing HeLa cells presents the SEM for eight cells. The half 
time of recovery was 20 s with an immobile fraction of 10%.
 
Table I. 
 
ATP reduction in HeLa cells
Time ATP
 

 
M
 
Control 2,170 
 

 
 50
30 min 620 
 

 
 14
45 min 366 
 

 
 11
Cells were grown in 2 mM 2-deoxyglucose and 5 mM sodium azide in the
absence of glucose for the indicated times. Cell ATP levels were measured
by luciferase assay as described in Materials and methods. Data points were
reported as the mean 
 

 
 SD of three replicates.
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ing the mobility and binding of nuclear proteins. Cells sta-
bly expressing EGFP-SRm160 were extracted in 50 
 

 
g/ml
digitonin to permeabilize the cell membrane without re-
moving the nuclear envelope, a preparation previously
used to study nucleocytoplasmic transport (Adam et al.,
1990). We verified that the nuclear envelope remained im-
permeable to macromolecules by incubation with primary
antibodies against the nuclear proteins SRm300 (Fig. 2),
SRm160, and NuMA (not depicted) and fluorescently
tagged second antibodies. These macromolecules did not
penetrate the nuclear envelope. In this preparation, larger
molecules, including EGFP-SRm160, are constrained to
the nucleus, whereas ATP and other molecules smaller
than the diffusion limit for nuclear pores (40–60 kD) are
depleted from nuclei. ATP levels decline to 1 nM or less in
these nuclei (Ribbeck et al., 1999). After photobleaching
EGFP-SRm160 in the regions of single speckled domains,
there was no detectable recovery of fluorescence in these
digitonin-permeabilized cells (Fig. 3). However, supple-
mentation with 5 mM ATP restored the apparent mobility
of EGFP-SRm160 (Fig. 3). Recovery was slower and the fi-
nal recovery diminished to 
 

 
60% compared with 90% in
living cells (compare Fig. 4 with Fig. 1 B).
After one round of ATP supplementation, extensive rins-
ing to remove ATP abolished recovery after photobleaching,
but mobility could be restored by adding 5 mM ATP for a
second time (Fig. 3 B), establishing that the continuing pres-
ence of ATP was required for maintaining mobility. How-
ever, the second addition of ATP resulted in a significantly
increased immobile fraction of SRm160. In some experi-
ments, EGFP-SRm160 in the nucleus of the same cell was
photobleached while the cell was alive (mobile), after digito-
nin permeabilization (immobile), and eventually after ATP
supplementation (mobile again).
To characterize the mechanism for the ATP-dependent
mobilization of SRm160, digitonin-permeabilized cells were
supplemented with either ADP, the nonhydrolyzable ATP
analogue AMP-PNP, or GTP. ADP did not significantly re-
store fluorescence recovery (Fig. 4). The nonhydrolyzable
ATP analogue AMP-PNP restored EGFP-SRm160 mobili-
zation in a manner indistinguishable from ATP (Fig. 4),
suggesting that ATP-induced conformational changes rather
Figure 2. Digitonin permeabilized cells have 
an intact nuclear envelope. HeLa cells were 
permeabilized with Triton X-100 (a and b) or 
digitonin (c and d) before treatment with the 
B4A11 mAb against SRm300 and an Alexa 
488–conjugated second antibody. Micrographs 
were collected using matched exposures so 
that cell fluorescence could be quantitatively 
compared. The antibodies were able to penetrate 
into the nuclear interior in Triton X-100–
permeabilized cells. In contrast, nuclei of 
digitonin-permeabilized cells were devoid of 
fluorescence showing that the nuclear envelope 
remained intact. Bars, 10 m.
Figure 3. ATP supplementation restores EGFP-SRm160s mobility. (A) HeLa cells stably expressing EGFP-SRm160 were permeabilized with 
digitonin before photobleaching. Bleached areas are indicated by the white squares. Images were collected before (Pre-Bleach), immediately 
after (Bleach), and at intervals after photobleaching (3 and 6 min). EGFP-SRm160 was immobile in permeabilized cells, and bleached areas 
did not recover their fluorescence (top). In contrast, EGFP fluorescence was restored in the bleached areas of ATP (5 mM )-supplemented cells 
(bottom), indicating that EGFP-SRm160 has an ATP-dependent mobility. Bars, 10 m. (B) HeLa cells were permeabilized with digitonin, 
replenished with 5 mM ATP, and photobleached (ATP1). The cells were washed extensively with import buffer to withdraw the ATP and 
photobleached again (wash). Finally, 5 mM ATP was added for a second time before a second round of photobleaching (ATP2). The curves 
represent the SEM for the indicated number of cells. ATP withdrawal stops the apparent mobility of SRm160, but readdition of ATP restores 
mobility again.
 o
n
 July 8, 2008 
w
w
w
.jcb.org
D
ow
nloaded from
 
 Published March 15, 2004
 846 The Journal of Cell Biology 
 
|
 
 
 
Volume 164, Number 6, 2004
 
than protein phosphorylation may mediate the relocalization
of SRm160 or its complexes. Addition of GTP resulted in
only a 20% recovery after bleaching (Fig. 4). ATP and GTP
did not work synergistically because they allowed no further
or faster recovery than ATP alone (Fig. 4).
Next, we used the in vitro FRAP assay to characterize the
mobility of other nuclear proteins. Transiently expressed
EGFP-hnRNP A2 was a useful control. It was distributed
throughout the nucleoplasm, slightly enriched in nucleo-
plasmic foci, and excluded from nucleoli (Fig. 5 A). The half
time of recovery was 
 

 
15 s with an immobile fraction of
 

 
30% (Fig. 5, A and D). In contrast to EGFP-SRm160,
digitonin permeabilization did not slow the fluorescence re-
covery of EGFP-hnRNP A2 (Fig. 5 A), suggesting that
hnRNP A2 mobility does not require ATP or other cofac-
tors small enough to diffuse through nuclear pores.
SRm160 participates in RNA splicing as a coactivator and
a constituent of spliceosomes (Blencowe et al., 1998, 2000)
and in RNA export as a constituent of the EJC (Le Hir et al.,
2000a,b, 2001). The SRm160 binding protein SRm300 is
also present in spliceosomes (Blencowe et al., 1994, 2000)
but is not detected in the EJC. EGFP-SRm300 in transiently
transfected HeLa cells colocalized with SRm160 in splic-
ing speckled domains (unpublished data). After the pho-
tobleaching of speckled domains, EGFP-SRm300 fluores-
cence recovered with a half time of 10 s (Fig. 5, B and D).
Approximately 10% of EGFP-SRm300 remained immobile
(Fig. 5 D).
In digitonin-permeabilized cells, EGFP-SRm300 fluo-
rescence recovery was greatly reduced with only 8% recov-
ery observed after 6 min (Fig. 5, B and E). Mobilization
was not restored by ATP supplementation (Fig. 5, B and
E), and the slight recovery observed in permeabilized cells
was suppressed by ATP addition. This finding suggests
that SRm300 requires factors other than ATP for move-
ment within the nucleus. When SRm160 is relocalizing af-
 
ter ATP supplementation, it cannot be moving in a com-
plex containing SRm300.
However, the protein RNPS1 is detected in the EJC
(Kataoka et al., 2001; Le Hir et al., 2000a,b, 2001). EGFP-
RNPS1 was most concentrated in splicing speckled domains
with a smaller nucleoplasmic pool when transiently expressed
in HeLa cells (Fig. 5 C). The half time of recovery after pho-
tobleaching in living cells was 
 

 
10 s with an immobile frac-
tion of 
 

 
40% (Fig. 5 D). Mobility completely stopped after
digitonin permeabilization (Fig. 5 C) but could be substan-
tially restored by ATP addition (Fig. 5, C and E). This recov-
ery was slower than in living cells and only reached 30%
compared with 60% for living cells (Fig. 5 E).
A second and complimentary approach was developed to
assess the ATP dependence of SRm160 release from binding
sites at speckled domains. This approach was done to con-
firm the results obtained from the in vitro FRAP assay and
to rule out the possibility that the EGFP portion of the fu-
sion protein was contributing to ATP-dependent relocaliza-
tion. HeLa or SAOS cells were permeabilized and soluble
proteins were extracted from both nucleus and cytoplasm
with 0.5% Triton X-100 in cytoskeletal buffer with or with-
out ATP. In contrast to digitonin treatment, this extraction
removes the nuclear envelope, allowing diffusing nuclear
proteins to leave. In some experiments, a soluble nuclear ex-
tract was added. As previously reported (Wan et al., 1994;
Blencowe et al., 1998), treatment in the absence of ATP did
not release SRm160 from either splicing speckles or from
the nucleoplasm (Fig. 6 A). However, in the presence of
ATP, most SRm160 was released. In contrast, the fluores-
cence intensity of SRm300 was only modestly reduced (Fig.
6 A).  Thus, the endogenous SRm160 is released from splic-
ing speckled domains in an ATP-dependent manner just as
the fluorescent fusion protein.
We have shown that the localization of SRm160 to splic-
ing speckled domains and its attachment to the nuclear ma-
trix is conferred by two domains of the protein: amino acids
300–350 and 351–688 (Wagner et al., 2003). Both domains
were also important for the ATP dependence of FRAP
recovery: EGFP-SRm160 221–350, containing the first
speckle targeting sequence and EGFP-SRm160 350–688,
harboring the second recovered in an ATP-dependent man-
ner (Fig. 7) but with a larger immobile fraction than the
full-length protein (Fig. 4). Thus, the ATP-dependent re-
covery of SRm160 may depend on both splicing speckle do-
main targeting sequences.
 
Discussion
 
Using a new in vitro FRAP assay, we have shown that the
apparent mobility of SRm160 depends on ATP. Although
we continue to use traditional FRAP terminology, our
interpretation of these FRAP experiments is that they
are measuring the binding of SRm160 to sites at splic-
ing speckled domains. There is no recovery after photo-
bleaching under conditions where EGFP-SRm160 remains
tightly bound. Addition of ATP allows for the unbinding
and exchange of bleached and unbleached proteins. A gen-
eral theoretical model for this interpretation of FRAP ex-
periments has been developed (Lele, T., P. Oh, and D. Ing-
ber, personal communication) and builds on previous
Figure 4. The nucleotide specificity of EGFP-SRm160 mobility 
in digitonin-permeabilized cells. HeLa cells stably expressing 
EGFP-SRm160 were permeabilized with digitonin. Before 
photobleaching, either buffer alone, 5 mM ADP, ATP, GTP, or 
AMP-PNP, or a combination of ATP and GTP (5 mM each) were 
added. Each point represents the mean for the number of photo-
bleached cells indicated in parentheses to the right of the curve.
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Figure 5. Photobleaching recovery of EGFP-
hnRNPA2, EGFP-SRm300, and EGFP-RNPS1 
in live and digitonin-permeabilized cells. 
(A) HeLa cells transiently expressing EGFP-
hnRNPA2 were photobleached. Recovery is 
shown for the same cell before (top) and after 
(bottom) digitonin permeabilization. Images 
were taken before (Pre-bleach), immediately 
after (Bleach), and at the indicated intervals 
after bleaching. The bleached area is outlined 
by a white square. Bar, 10 m. (B) HeLa cells 
transiently expressing EGFP-SRm300 were 
photobleached. Recovery is shown for a live 
cell (top), after digitonin permeabilization 
(middle), and after addition of 5 mM ATP to 
a permeabilized cell (bottom). Images were 
taken before (Pre-bleach), immediately after 
(Bleach, and at intervals after bleaching. The 
bleached area is outlined by a white square. 
EGFP-SRm300 does recover in live cells but 
not in digitonin-permeabilized cells with (bot-
tom) or without (middle) ATP supplementa-
tion. Bars, 10 m. (C) HeLa cells transiently 
expressing EGFP-RNPS1 were photobleached. 
Recovery is shown for a live cell (top), after 
digitonin permeabilization (middle), and 
after addition of 5 mM ATP to a permeabilized 
cell (bottom). Images were taken before 
(Pre-Bleach), immediately after (Bleach), and 
at the indicated intervals after the bleach. The 
bleached area is outlined by a white square. 
EGFP-RNPS1 becomes immobile in digitonin-
permeabilized cells (middle), but substantial 
recovery was restored upon ATP addition 
(bottom). Bars, 10 m. (D) Photobleach 
recovery curves for EGFP-hnRNP A2, EGFP-
SRm300, and EGFP-RNPS1 in live cells are 
plotted as the SEM for the indicated number 
of cells. The half times for recovery were 15 s for EGFP-hnRNP A2, 10 s for EGFP-SRm300, and 10 s for EGFP-RNPS1. (E) Photobleach recovery 
curves for EGFP-SRm300 and EGFP-RNPS1 in digitonin permeabilized cells before and after addition of ATP are plotted as the SEM for the 
indicated number of cells. ATP supplementation restored mobility to 30% of EGFP-RNPS1 but did not increase EGFP-SRm300 recovery.
 o
n
 July 8, 2008 
w
w
w
.jcb.org
D
ow
nloaded from
 
 Published March 15, 2004
 848 The Journal of Cell Biology 
 
|
 
 
 
Volume 164, Number 6, 2004
 
interpretations of FRAP data as binding measurements
(Phair and Misteli, 2001).
When SRm160 is exchanging and diffusing in the pres-
ence of ATP, it could be alone, in an RNA splicing complex
(Blencowe et al., 1994, 2000), or in an RNA export com-
plex (Kataoka et al., 2001; Le Hir et al., 2000a,b, 2001).
SRm300 is a binding partner of SRm160 and, with
SRm160, a constituent of spliceosomal complexes but has
not been detected in the RNA export-related EJC. SRm300
apparent mobility was not restored by ATP, so SRm300
cannot be in a complex with SRm160 during ATP-induced
mobilization. In contrast, RNPS1 is together with SRm160
in RNA export complexes (Kataoka et al., 2001; Le Hir et
al., 2000a,b, 2001) and had a similar ATP-dependent mo-
bility. This finding is consistent with an ATP-dependent
unbinding of SRm160-containing RNA export but not of
splicing complexes.
ATP hydrolysis was not required for SRm160 mobilization
because the nonhydrolyzable analogue AMP-PNP restored
fluorescence recovery as well as ATP (Fig. 4). Thus, ATP-
induced conformational changes rather than phosphorylation
events may mediate the mobilization of SRm160 or its
complexes. GTP only partially restored the mobilization of
SRm160 and there was no synergistic effect of ATP and
 
GTP. There may be two NTP-dependent mechanisms for
SRm160 fluorescence recovery, each regulating the mobiliza-
tion of distinct forms or complexes of SRm160. One mecha-
nism would have a strict requirement for ATP, whereas the
second would use either ATP or GTP. There would be ap-
proximately twice as many complexes with ATP-dependent
compared with NTP-dependent mobility (Fig. 4).
SRm160 and the other splicing and RNA export factors
studied here are most concentrated in splicing speckled do-
mains, and our experiments directly measure its binding at
those sites. Regulated binding at these sites, where a majority
of pre-mRNAs are spliced (Smith et al., 1999), might repre-
sent a mechanism for retaining transcripts until their pro-
cessing is completed. Further, if similar ATP-dependent
binding mechanisms exist at nucleoplasmic sites between
splicing speckled domains and the nuclear pores through
which mRNA leaves the nucleus, then a simple mechanism
for channeling RNA export could be proposed. Export com-
plexes containing SRm160 and RNPS1 might diffuse in the
nucleoplasm but be constrained to defined paths by occa-
sional, transient docking to binding sites along a path. A
similar controlled diffusion mechanism has been proposed
for the export of NOP140-containing complexes (Meier and
Blobel, 1992). Consistent with this model, we have observed
SRm160 strung along long nuclear tracks by immunoelec-
tron microscopy (unpublished data). In this model of nu-
clear export regulation, complexes with bound ATP would
be diffusing but complexes with ADP would be docked on
structures. Regulation of ATP exchange or hydrolysis would
select complexes for release and export. Consistent with this
model for regulated RNA export is the recent demonstration
by in vivo FRAP that the intranuclear mobilities of poly(A)
binding protein II and TAP are reduced in cells after treat-
ment with azide and 2-deoxyglucose or after temperature re-
duction (Calapez et al., 2002). Both proteins may be in
mRNP complexes during export.
More generally, the binding and exchange of small regu-
latory molecules like ATP might control the relocation of
other complexes in the nucleus. This relocation might be
achieved by regulating the release of these complexes from
one binding site on a relatively immobile nuclear struc-
ture, like chromatin or the nuclear matrix, and permitting
their subsequent binding at a new site. The advantage of
regulated release might be that complexes are retained un-
til they are completely assembled or processed. Further,
the intranuclear geometry of specific binding sites might
channel diffusion of molecules or complexes along pre-
Figure 6. The release of endogenous SRm160 
from Triton X-100–permeabilized cells is ATP 
dependent. HeLa cells were permeabilized in 0.5% 
Triton X-100 in the presence of 20 mM ATP (ATP) 
or without ATP (ATP). SRm160 and SRm300 were 
detected by immunofluorescent staining using the 
mAbs B1C8 and B4A11, respectively. In the presence 
of ATP, the large majority of SRm160 is released 
during the permeabilization, whereas most SRm300 
is retained. Projections of confocal data stacks are 
shown. Images were collected using identical 
machine settings so that the images could be 
compared quantitatively. Bar, 10 m.
Figure 7. SRm160 domains conferring ATP-dependent mobilization. 
HeLa cells transiently expressing the indicated EGFP-SRm160 deletion 
mutants were permeabilized with digitonin and FRAP performed 
in the presence of 5mM ATP. In the absence of ATP, there was no 
detectable recovery. Each point represents the mean for the number of 
photobleached cells indicated in parentheses to the right of the curve.
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ferred paths. In vitro FRAP provides an assay for uncover-
ing such mechanisms and identifying the small molecules
that may regulate them.
The energy dependence of nuclear protein mobility has pre-
viously been assessed by measuring photobleaching recovery
rates after metabolic inhibitor treatments to reduce ATP levels
or after reducing cell temperature. The intranuclear mobilities
of ASF/SF2, fibrillarin, and HMG-1 are unchanged after
cooling cells from 37
 

 
 to 23
 

 
C and after treatment of cells
with sodium azide (Phair and Misteli, 2000). In contrast, the
estrogen receptor immobilizes in cells treated with sodium
azide and 2-deoxyglucose, suggesting an energy-dependent
mobility. ATP involvement in the nuclear mobility of Cajal
bodies is supported by their faster movement in sodium azide/
2-deoxyglucose-treated cells studied by time-lapse microscopy
(Platani et al., 2002). A negative result in metabolic inhibitor
studies is difficult to interpret without a direct measurement
of the resulting ATP levels. Treatment with sodium azide and
2-deoxyglucose for 45 min did not reduce measured ATP lev-
els (Table I) sufficiently to severely compromise SRm160 mo-
bility. Therefore, inhibitor experiments in living cells may un-
derestimate, or miss entirely, the ATP dependence of mobility
for some proteins and their complexes.
A preferable approach to measure the ATP dependence of
nuclear protein binding and mobility is the in vitro FRAP
assay we introduce here. This same system can be used to de-
plete, and then supplement molecules, other than ATP so
long as they are small enough to diffuse through nuclear
pores. Even smaller nuclear proteins (
 

 
40–60 kD) can be
depleted. This system offers an unprecedented ability to
biochemically manipulate and characterize mobility pro-
cesses in the nucleus. The rate of both EGFP-SRm160 and
RNPS1 mobilization was reduced in ATP-supplemented
permeabilized cells compared with living cells and there was
a higher percentage of each protein that remained in the im-
mobile fraction. This finding might be attributable to deple-
tion of other mobility cofactors, which are either smaller
than the diffusion limit of pores or which are exported from
the nucleus by ATP or its analogs (Englmeier et al., 1999).
FRAP of digitonin-permeabilized cells offers an assay for the
future identification of such additional cofactors. More gen-
erally, mobility studies using digitonin-permeabilized cells
are a valuable tool for identifying cofactors affecting the nu-
clear dynamics of proteins, complexes, and structures.
 
Materials and methods
 
Plasmids
 
The expression vector and method used to establish EGFP-SRm160–
expressing cells has been described previously (Wagner et al., 2003).
EGFP-SRm300 was established by assembling a full-length cDNA for
SRm300 that was subsequently cloned into the pEGFP-C3 expression vector
(CLONTECH Laboratories, Inc.). The SRm300 sequence was verified by se-
quencing. EGFP-hnRNP A2 was obtained by inserting the hnRNP A2 cDNA
(provided by G. Dreyfus, University of Toronto, Toronto, Canada) from
pET28a-hnRNP A2 (Kamma et al., 1999) into pEGFP-C1 (CLONTECH Labo-
ratories, Inc.). To generate EGFP-RNPS 1, the cDNA for RNPS1 (provided
by B. Blencowe, University of Pennsylvania, Philadelphia, PA) was ampli-
fied by PCR and inserted into pEGFP-C1 (CLONTECH Laboratories, Inc.).
 
Cell culture
 
HeLa cells were cultured in DME supplemented with 10% FBS. Transfec-
tions were performed using Superfect (QIAGEN). HeLa cells stably ex-
 
pressing EGFP-SRm160 were obtained by selection with G418 followed by
FACS
 
®
 
 analysis for EGFP-positive cells and analysis of cell lines derived
from single cell clones. For FRAP experiments, cells were grown on 40-
mm glass coverslips and transferred to the FCS2 live cell chamber
(Bioptechs) mounted on an SP laser scanning confocal microscope (Leica)
with objective heater. The temperature was maintained at 37
 

 
C. To perme-
abilize cells, the medium was replaced with 50 
 

 
g/ml digitonin in perme-
abilization buffer (20 mM Hepes, pH 7.3, 110 mM potassium acetate, and
2 mM magnesium acetate) for 6 min. Afterward, the cells were washed
with permeabilization buffer for 10 min. In some experiments, cells were
incubated in permeabilization buffer containing either 5 mM ATP (Sigma-
Aldrich), GTP (Sigma-Aldrich), AMP-PNP (Roche), or ADP (Calbiochem)
for at least 5 min before FRAP measurements.
 
Antibody penetration assay
 
Antibody penetration assay was performed as described by Adam et al.
(1990). HeLa cells grown on coverslips were extracted with either 0.5%
Triton X-100 or 50 
 

 
g/ml digitonin in permeabilization buffer at RT for 6
min. Cells were treated with the mAb B4A11 against SRm300 for 10 min
and washed with permeabilization buffer. Next, the cells were incubated
with an Alexa 488–conjugated secondary antibody (Molecular Probes) for
10 min, washed with permeabilization buffer, and fixed with 4% formal-
dehyde in cytoskeletal buffer (Blencowe et al., 1998).
 
ATP depletion and measurement
 
To reduce ATP levels, HeLa cells were incubated in glucose-free Opti-
MEM (GIBCO BRL) with 6 mM 2-deoxyglucose (Sigma-Aldrich) and 10
mM sodium azide for up to 45 min. Cell extracts were prepared by incu-
bation in 100 mM Tris, pH 7.75, and 4 mM EDTA at 100
 

 
C for 2 min.
ATP levels were measured by luciferase assay using an ATP assay kit
(Calbiochem).
 
Fluorescence recovery after photobleaching
 
Images of the nucleus were scanned before and after bleaching at low
laser power. Routinely, two images were taken before and 20–30 im-
ages after the bleach at intervals of 1.6 or 20 s depending on the time of
recovery. To destroy EGFP fluorescence, maximal laser power was ap-
plied to a region of interest for 3 s. Confocal Software (version 2; Leica)
was used to measure the intensity of fluorescence in the bleached area
and in the whole nucleus for the whole stack of images. For analysis,
these data were transferred into a Microsoft Excel spreadsheet. Any re-
maining fluorescence in the bleached area after the bleach was normal-
ized to zero. The relative fluorescence intensity (I
 
rel
 
) in the previously
bleached area was calculated as described by Phair and Misteli (2000):
I
 
rel
 
 
 

 
 T
 
0
 
 I
 
f
 
/T
 
t
 
 I
 
0
 
, with T
 
0
 
 being the total cellular intensity before bleach, T
 
t
 
the total cellular intensity at time t, I
 
0
 
 the intensity in the bleached area
before bleach, and I
 
f
 
 the intensity in the previously bleached area at
time t. Recovery curves were drawn using Kaleidagraph 3.5 (Synergy
Development). The percentage of immobile protein was determined as
the difference between the plateau of any given recovery curve and a
relative recovery of 1, a value that would reflect complete recovery
without an immobile fraction. For example, a plateau at 0.8 reflects an
immobile fraction of 20%.
 
Nuclear protein release assay
 
HeLa cells (CCL2) grown on coverslips were washed in PBS at 37
 

 
C for 2
min. They were permeabilized at 37
 

 
C for 10 min in 0.5% Triton X-100 in
cytoskeletal buffer in the presence of 20 mM ATP or without ATP before
fixation at 4
 

 
C in 4% formaldehyde. SRm160 was detected by immunoflu-
orescent staining using the SRm160-specific mAb B1C8 (mouse IgM), and
SRm300 was detected using mAb B4C11 (mouse IgG), followed by an Al-
exa 488–conjugated goat anti–mouse IgM and Alexa 568–conjugated goat
anti–mouse IgG secondary antibody (Molecular Probes) for 1 h at RT. Cov-
erslips were mounted with Prolong (Molecular Probes).
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